Scpharmaceuticals inc. (SCPH)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17
Assets
Current assets
Cash and cash equivalents

75,339

72,624

83,562

79,467

83,378

89,478

95,299

100,768

109,280

118,298

Prepaid expenses

3,370

2,619

894

1,658

1,770

1,757

981

1,608

1,323

823

VAT receivable

305

310

303

500

494

479

454

438

830

655

Other current assets

59

94

128

148

169

179

97

151

135

107

Total current assets

79,073

75,647

84,887

81,773

85,811

91,893

96,831

102,965

111,568

119,883

Restricted cash

182

182

182

182

182

182

182

182

182

182

Property and equipment, net

119

127

136

145

154

164

215

225

193

203

Right-of-use lease assets - operating, net

1,092

1,179

1,264

1,347

1,427

1,506

1,582

1,629

1,702

1,773

Deposits and other assets

22

148

197

12

13

10

9

8

7

7

Total assets

80,488

77,283

86,666

83,459

87,587

93,755

98,819

105,009

113,652

122,048

Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable

652

1,142

542

1,419

221

587

1,667

2,358

1,519

1,591

Accrued expenses

3,590

3,688

7,169

7,110

5,474

2,922

2,212

2,565

2,736

3,063

Term loan, short term

-

-

-

4,624

4,035

2,811

3,210

2,231

1,265

314

Current portion of lease obligation - operating

421

407

393

379

366

353

341

309

276

242

Other current liabilities

-

-

-

-

-

-

-

-

4

1

Total current liabilities

4,663

5,237

8,104

13,532

10,096

6,673

7,430

7,463

5,800

5,211

Term loan, long term

18,996

18,915

18,842

5,086

5,649

6,826

6,421

7,331

8,222

9,105

Long term lease obligation - operating

832

943

1,052

1,156

1,255

1,353

1,448

1,514

1,599

1,683

Derivative liability

795

765

766

-

-

-

-

-

-

-

Other liabilities

98

58

16

216

189

159

130

109

87

52

Total liabilities

25,384

25,918

28,780

19,990

17,189

15,011

15,429

16,417

15,708

16,051

Commitments and contingencies (Note 10)

-

-

-

-

-

-

0

0

0

-

Stockholders’ equity
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding

-

-

-

-

-

-

0

0

0

-

Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2020; 19,418,955 and 20,981,880 shares issued and outstanding as of December 31, 2019 and March 31, 2020, respectively

2

2

2

2

2

2

2

2

2

2

Additional paid-in capital

191,649

180,818

176,524

175,900

175,574

175,201

174,748

174,189

173,690

173,011

Accumulated deficit

-136,547

-129,455

-118,640

-112,433

-105,178

-96,459

-91,360

-85,599

-75,748

-67,016

Total stockholders’ equity

55,104

51,365

57,886

63,469

70,398

78,744

83,390

88,592

97,944

105,997

Total liabilities and stockholders’ equity

80,488

77,283

86,666

83,459

87,587

93,755

98,819

105,009

113,652

122,048